May 24, 2021
Learning & Development
ATA Podcast

An Interview with Ron Emerson, Global Healthcare Lead at Zoom

Greg Matthews, Founder of HealthQuant, recently sat with Ron Emerson, Global Healthcare Lead for Zoom, for a conversation about how Zoom became not only the dominant videoconferencing platform, but an actual part of our Lexicon. They’ll also dive into how an industry-agnostic platform has developed such deep healthcare presence in such a short time – and a look at what the future holds for the company and the telehealth industry.

Zoom Healthcare: https://zoom.us/healthcare

Ron on LinkedIn: https://www.linkedin.com/in/ron-emerson-link/ 

Ron on Twitter: https://twitter.com/Emerson1Ron









Related Resources


ATA Podcast Series
Health Virtually Uncensored Season 2 Episode 3

How Forward-Thinking Healthcare Leaders Can Inspire and Support Innovation
April 15, 2024
Made possible by Fabric Health
How can we reconstruct American healthcare by bridging traditional academic centers with entrepreneurs and innovators? Join Drs. Stephen Klasko, a former university president, dean, CEO, and an obstetrician, and now an executive in residence at General Catalyst – and lifelong DJ, and Joe Kvedar to explore how healthcare executives can imagine and build a more accessible, high-quality and equitable healthcare system.

   Podcast
Webinars
Maximizing Provider Capacity and Improving Access with Asynchronous Care
April 5, 2024
ATA's Async Telehealth Special Interest Group
With increasing provider shortages, patient wait times, and physician burnout, maximizing clinical capacity has become more critical than ever. Discover why leading direct-to-consumer health brands and provider organizations are turning to the power of asynchronous care to address these challenges.

   View Video
Webinars


Policy Update: Navigating the DEA's Geographic Red Flag in Remote Prescribing
March 29, 2024
ATA
This policy update dives into the geographic red flag issue specific to the Drug Enforcement Administration’s (DEA) oversight of remote prescribing of controlled substances. We clarify the issue, outline the key players involved, discuss potential DEA rulemaking as well as its potential impact on state policies, and highlight the urgent stakeholder statement urging the DEA to address this issue.

   View Video